Austin Regional Clinic to begin COVID-19 vaccine trial
August 07, 2020
Austin Regional Clinic recently began recruiting for a COVID-19 vaccine clinical trial set to begin this month. In this interview on KVUE News, Director of ARC Clinical Research Jeff Repper said the study offers participants an opportunity to be a part of history and benefit humankind.
“It is the top priority of the US and the world to find a successful vaccine to prevent the infection and spread of COVID-19,” said Dr. Gretchen Crook, principal investigator for ARC Clinical Research. “This vaccine candidate has the potential to save lives and allow us to return to a way of life that will restore our economy, re-connect our friendships, and continue activities we all enjoy.”
COVID-19 Vaccine Trial
ARC is seeking 250 volunteers from across Central Texas to enroll in this late phase clinical trial. The trial is open to healthy adults between age 18 and 85. People who have had a known positive case of COVID-19 or who are immunocompromised are not eligible to participate.
“There are 7 billion people in our world who will need access to a vaccine to prevent COVID-19 infection and ARC Clinical Research is thrilled to have a role in bringing a vaccine to Americans,” said Repper.